In 2022, Lynn Seely earned $650.00K in total compensation at Lyell Immunopharma, Inc., primarily from $650.00K salary. Most recently acquired 525,000 shares in Mar 2025. Currently holds stock worth $2.24M. 2+ years at the helm of Lyell Immunopharma, Inc..
Compensation History
Annual executive compensation data for Lynn Seely, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$650.00K
Salary
$650.00K
Bonus
$0.00
Other
$0.00
Salary
$650.00KBoard Justification
The compensation philosophy is designed to attract and retain talented individuals who possess the skills necessary to manage and grow the business, facilitate the achievement of strategic goals, and create long-term value for stockholders.
Bonus
$0.00Board Justification
Dr. Seely commenced employment on December 15, 2022 and was not eligible for an annual bonus payment based on 2022 corporate goals.
Other Compensation
$0.00Board Justification
No additional compensation was reported for Dr. Seely in 2022.
Restricted Stock
Board Justification
No stock was vested in 2022 as Dr. Seely received an initial equity award in December 2022 upon her appointment.
Performance Metrics
The performance metrics for 2022 were based on corporate goals approved by the Board of Directors, but Dr. Seely was not eligible for bonuses as she commenced employment in December 2022.
Lynn Seely
CEO of Lyell Immunopharma, Inc.
Education
M.D. from the University of Oklahoma College of Medicine
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1970 - 55 years ago
CEO of Lyell Immunopharma, Inc. for
2 years 11 months (Dec 2022 - Present)
Previous Experience
Former President and Chief Executive Officer at Myovant Sciences
Other Lyell Immunopharma, Inc. CEOs
Holdings
Track Lynn Seely's stock holdings and portfolio value over time.
Insider Trading
Lynn Seely's recent stock transactions, purchases, and sales filed with the SEC.
$318.57K
LYEL at $0.61/share
Mar 14, 2025
Purchase
675,000 shares
LYEL
Feb 10, 2025
Received
2,242 shares
BPMC
Jun 12, 2024
Received
200,000 shares
LYEL
Feb 9, 2024
Received
2,600 shares
BPMC
Jun 21, 2023
Received
2,600 shares
BPMC
Jun 21, 2022
Received
2,250 shares
BPMC
Jun 2, 2021
Received
2,250 shares
BPMC
Jun 24, 2020
Received
Rivals
Compare Lynn Seely with competitor CEOs and industry peers.